Speed Kills: When Timelines Trump Science In Neuropsychiatric Trials

Psychedelic research is entering a defining moment. Programs are advancing, data are emerging, and the field is learning in real time what works and what needs to evolve. Yet many foundational elements of trial design, therapy delivery, and communication are still taking shape. This Bold Conversation brings together experts helping to define the next chapter of psychedelic clinical research to unpack lessons from recent regulatory reviews and explore what clinical teams need now to move forward with confidence, consistency, and scientific integrity.